Article
New discoveries in progressive myoclonus epilepsies: a clinical outlook.
Expert review of neurotherapeutics - 1 Aug 2018
Bhat Shweta, Ganesh Subramaniam
Abstract excerpt
INTRODUCTION: Progressive myoclonus epilepsies (PMEs) constitute a rare and heterogeneous group of genetic disorders with a distinctive triad of myoclonus, seizures, and progressive neurological deterioration. PMEs, even though rare, are arguably the severest form of epilepsies accounting for <1% of all epilepsies with age at onset varying from infancy to adulthood, depending on the disease. A majority are...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
